{"name":"Yoon Jun Kim","slug":"yoon-jun-kim","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GODEX","genericName":"GODEX","slug":"godex","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"GODEX","genericName":"GODEX","slug":"godex","phase":"phase_3","mechanism":"GODEX is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOaTJ4UzBJSTZOTzhRcVF1VVhsRzhSZWJmNS1TTGhJMkVoM20yY0tpa1VhaGVNNml2M2xLR0s0WFBqb3VuYkxOQjN5S3MtbHBkQ3VKM3BCbHlPT3Qtckh0LU1MT0Z6SGt0Rm5jQlI4emlDdGJGd2F6cXNQYWpkZ3IxbtIBlAFBVV95cUxNODBvTDhLSndVLUx2NHB5Mk1FX1FDUVFRNVZ0TkdRSnZtcVBnRVZ2UzdZY0pyR290b1BfQzNvWmdYQTU4V3RGMU5Cckp3V0lWUnFJckJkb19EX2F6ajRYRjU3NEN6SV9wWktGNDhPZUd5V3h2ZWxfVTUyVkltWmZfa2hRdEVuWjFFcVpTVVpaQWxITUpS?oc=5","date":"2026-03-31","type":"pipeline","source":"Chosunbiz","summary":"Hanmi Pharmaceutical names Hwang Sang-yeon first outsider CEO in 53 years - CHOSUNBIZ - Chosunbiz","headline":"Hanmi Pharmaceutical names Hwang Sang-yeon first outsider CEO in 53 years - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE1tcld0T2N3MTFqVG5QMFowYWpVZHNXR0xqaWNzRFdRQlVNaGVSMm1pZnVhX1RCYXFZTWhTV0Q5Tnk0cjN4WDFTM1VIMA?oc=5","date":"2026-03-12","type":"pipeline","source":"매일경제","summary":"The second term of Hanmi Pharmaceutical CEO Park Jae-hyun, who has been at odds with Hanyang Precisi.. - 매일경제","headline":"The second term of Hanmi Pharmaceutical CEO Park Jae-hyun, who has been at odds with Hanyang Precisi.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOVVZ2STRNYUJJWms1R2U5NlFuM3JfSnhsYWRuSkF2VDdLR2J2MEFPLVNvVVdvTGZ2b2VfQ1pOd1ZKYnpsNjlRV1N4bE5MaVpXUjBZaUE4MGozMmhwU2Q5ZHBXS2RSM0N5OWNnVVZZR2J1X2hUeGZiWjhFX3pjNDRIV9IBlAFBVV95cUxNNmJlVWstSDNtc0xXNjlUQTJmTDhHTWxEZnhVSmNxTF9KZkhsTC1kTkhNUW1IaGhLNFpWR2UwMDJtRE1TUFVhTU1aeWxyMHZzekJaeld4M1hjd3VFMF9sUUlzV0tJQmszbG5aTFJDV2pfLXBQcWRmNU9GWTdySmtLMUFHb2ladTZXNm9oR0FRenIzMlFF?oc=5","date":"2026-02-10","type":"pipeline","source":"Chosunbiz","summary":"Seoul court acquits LG heirs Koo Yeon-kyung and Yoon Kwan of insider charges - CHOSUNBIZ - Chosunbiz","headline":"Seoul court acquits LG heirs Koo Yeon-kyung and Yoon Kwan of insider charges - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9fdlREYURRemh1ZW1LZFRsakU4OElRLTFCX3B2aWxmdVNRLUhMLXdFNU9ZbktKWFh5Nl9lbE5zbkJXVWRGd0J1aTNRZlUyRUhhX3hORUt3M2pjZzlUMW5iY3E5NA?oc=5","date":"2025-12-05","type":"pipeline","source":"매일경제","summary":"‘Dear X’: Kim Yoo-jung’s Dazzling Fall... A Shocking Ending That Lingers - 매일경제","headline":"‘Dear X’: Kim Yoo-jung’s Dazzling Fall... A Shocking Ending That Lingers - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFB0cHVjRHBCQ0IyU1lqRzhGaDNzZEc1aUduQXd0QzVnbEc0c0FMd3BkYm83cXI1bngtY2RldFlJZzNCWk9BQVpXMjZfUXBsTzQzNUg4TmtR?oc=5","date":"2025-11-28","type":"pipeline","source":"매일경제","summary":"‘Dear X’ Kim Yoo-jung: “Working with Kim Young-dae and Kim Do-hoon—How Was It Different?” [Interview2] - 매일경제","headline":"‘Dear X’ Kim Yoo-jung: “Working with Kim Young-dae and Kim Do-hoon—How Was It Different?” [Interview2] - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQX1JlY0d1V2s0by1ZNW9IeWVUaUp5QTl4UUVqUWx3MEx2VExKNUYtbVhGT2RpMHdnbkZNNTlfMUVPWDFCaXZvbDBSZC1VcEU3M1czc0JWMTFGMVhrVlVYb1E1ODlCcDJJSmUxaHFaVldsNERaVjdCemM4Wk1sblhoY9IBlAFBVV95cUxQdkdPTU9rY0FJbDhSY085c2RucEllaTJOQWFHczliS1RJVEVQTkU0Y0h4bUpCX3JRWkJHVk1jYXBfSGFqTTNFd1hCdm8wMXBrb3NidnY5Q0tWX2hlOF8tNUNfSm1zUlZ3bVI3Qko2T1BwSUVpbHJJQXdxMWxtNmJrbW9BMFZWMm1NMEhHMUI2dG4xQllW?oc=5","date":"2025-11-13","type":"pipeline","source":"Chosunbiz","summary":"Korean pharma groups accelerate generational shift as family heirs assume CEO roles - CHOSUNBIZ - Chosunbiz","headline":"Korean pharma groups accelerate generational shift as family heirs assume CEO roles - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBDdlBmcDJoUVJUZC1yX3ZsRFdEWi1kUFdYRTVkWEJzM3RfNkVzaTdkSmJtYWZsR3g4QW9yUUd1Y0pSbkdBdWZZVUJycXlyVEtxY2pYMVZhVmhmTm5FTkhFZWNGVFlBM1A5Uk1FZlJn0gFyQVVfeXFMTlpFOHdTSU9YcWhncHBNemE2LW8ydElTVzRxbFVXcUVjY3lNZTVVLUZjYjBmZWVVZHctMDd1d2hDVlVxOEVNN3NJX1hzbENFOUNnOHhrd3BNQUF2QWoyNUwzbVAwWTNmVkVlYXRsdVBMMkVR?oc=5","date":"2025-11-11","type":"pipeline","source":"koreabiomed.com","summary":"Daewoong hosts Nabota BTX master class to strengthen brand in Argentina - koreabiomed.com","headline":"Daewoong hosts Nabota BTX master class to strengthen brand in Argentina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYTRmOVZXWFBUVVRTaTFjcGlUR0NnUzl3VWVNRjVtQUlJNW1rdWxrNnpqWHdFY2d1V3h0aGgzSVFGbXYzd2ZPQW9ORW44czkxR2MwWXV0VWZOUENGOTRIWlZMOXBaZnptRjJhM09LQ2hudnFLQkQtUjU5ZWtEWDFPUGo5aEdsalVq?oc=5","date":"2025-10-24","type":"pipeline","source":"조선일보","summary":"Kolon Group Appoints Kim Yeong-bom as Kolon Global CEO - 조선일보","headline":"Kolon Group Appoints Kim Yeong-bom as Kolon Global CEO - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBlbkwxd0lxTXFEZm0yTW52Wmx2Njdsb3ljc0lXbG1fOWFPbzRWZTVGT25Yc3gwaVloNWdfaExkTlpmUEVKRWQxYmwzcEZIQVFlRkhXVHNmYmdOLUo5b3RTenV6RmtERmItMjdDVHd30gFyQVVfeXFMTXdwSlNwT3ozSEZtbXptWVJySm1fUVhPYlFpLVZBeHBvUXZHbXktSE9ZSnZPSjVNQnNTY1NIVU84ZG1iQU9tM2FPLTlsWjlvdEktbmdpRW1EVmQ4V3dSMTRzVFJmeVQ3TkxjVnNWRFlDZWFR?oc=5","date":"2025-10-23","type":"pipeline","source":"koreabiomed.com","summary":"Boston Scientific’s TheraSphere reshapes liver cancer care in Korea as radioembolization eclipses chemo - koreabiomed.com","headline":"Boston Scientific’s TheraSphere reshapes liver cancer care in Korea as radioembolization eclipses chemo","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-21","type":"pipeline","source":"The Economic Times","summary":"Six new K-Dramas to watch this week on OTT starring Kim Young-kwang, Jun Ji-hyun, Im Yoon-ah: Walking on T - The Economic Times","headline":"Six new K-Dramas to watch this week on OTT starring Kim Young-kwang, Jun Ji-hyun, Im Yoon-ah: Walking on T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ubklVTHNsLS1ZQU9jVnJHUjRBamFZdE9SSEhjcEdiWER3d1QtVUtjTFQzNXhjZ2RHbXYzMU56azB6VC1lM2ItOURtekhPMDA5OUp0c3lQeEtMZkZ0bkRJ?oc=5","date":"2023-02-16","type":"trial","source":"nature.com","summary":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial - nature.com","headline":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNbm9WTFNXZ2F2dVRPQlotdFdLTjY2b1FhSUlJZ3MtRW1lS0g2T3R1bHRKdFY5TjR1ZEpLbFBiTFZxQW9XdG5pTHdDMHV4U3I5SjR4S0x2Ni05WnA1aDA4Z2R5MG94WXV6MnBWaFgtQ2RuWW9BcU5CUHdOUEFsLU85UmhpNy1Pcjd4QzE0UkNjblF1dnlSMFRSdUJpX3otcTlk?oc=5","date":"2022-03-29","type":"pipeline","source":"Business Wire","summary":"GC Pharma Changes Its Name to “GC Biopharma” - Business Wire","headline":"GC Pharma Changes Its Name to “GC Biopharma”","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}